Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Noveome Biotherapeutics

Request full access

A clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues

O'Hara Township, United StatesFounded 2000Biotech & Life Sciences

About Noveome Biotherapeutics

Noveome Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation biologics. The company's core product, ST266, is a biologic with unique and powerful healing potential, currently being tested in Phase I clinical trials for COVID-19 and various ophthalmic indications. Noveome operates in the biopharmaceutical market, targeting healthcare providers and patients in need of advanced treatments for serious conditions. The business model revolves around research and development, clinical trials, and eventual commercialization of their biologic products. Revenue is generated through partnerships, grants, and future sales of approved treatments. Noveome's innovative Cribriform Targeted Device (CT6) enhances drug delivery to the nasal cavity, ensuring high absorption and efficacy. The company is headquartered in Pittsburgh, PA, and is driven by a passionate team dedicated to making a positive impact on lives.

Source: Dealroom company data

At a glance

Status
Operational
Employees
30
Open positions
None listed
Dealroom signal
84.6/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES EOther financing Apr 2025 $51M $204M MAK Capital ↗
SERIES EOther financing Aug 2023 $21M $83M MAK Capital ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Noveome Biotherapeutics website traffic

Latest recorded traffic for Noveome Biotherapeutics is 2.8K monthly website visits, up 75% over the last three months. Noveome Biotherapeutics's team grew 3.4% over the past year.

Latest monthly visits2.8K 3-month web change+75% 1-year team growth+3.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Noveome Biotherapeutics in the O'Hara Township ecosystem

Live from Dealroom

The Noveome Biotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • US Department of Health and Human Services
  • US Department of War
  • Government of Pennsylvania

Series B and later2 investors entered at this stage

  • Miraki Innovation
  • MAK Capital
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Noveome Biotherapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Noveome Biotherapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.